Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2014-03-13 Earnings Release
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
Press release
Earnings Release Classification · 95% confidence The document is a press release titled '2013 annual results' issued by Guerbet. It provides a summary of key financial highlights (Revenue, EBITDA, Net Income, etc.) for the fiscal year 2013, along with management commentary and future outlook. While it contains financial data, it is structured as a press release rather than a full 10-K or comprehensive annual report. According to the filing definitions, an initial announcement of periodical financial results (key highlights only) is classified as an Earnings Release (ER). FY 2013
2014-03-13 English
Presse release
Board/Management Information Classification · 99% confidence The document is explicitly titled as a "PRESS RELEASE" and its primary content announces the appointment of Didier Izabel as a Director of Guerbet, replacing Vincent Dagommer. This directly relates to changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). The document length is short (2368 chars), but the content is the announcement itself, not a notice about another report, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule for this specific content type.
2014-03-12 English
Communiqué de presse
Board/Management Information Classification · 98% confidence The document is a press release announcing the co-optation (appointment) of Didier Izabel as a new member of the Board of Directors, replacing Vincent Dagommer. This directly concerns changes in the company's board of directors and senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and structured as an official announcement, not a comprehensive report like a 10-K or IR.
2014-03-12 French
Press Release
Earnings Release Classification · 90% confidence The document is clearly labeled as a "PRESS RELEASE" and announces a specific corporate event: receiving FDA approval for a new manufacturing plant for Lipiodol®. It contains key highlights, management quotes, and product safety information, typical of an initial announcement of results or significant operational news. It is not a comprehensive annual report (10-K), an interim report (IR), a transcript (CT), or a formal regulatory filing like a proxy statement. Since it is an initial announcement of a significant operational/regulatory milestone, it best fits the 'Earnings Release' (ER) category, which often serves as the general category for major, non-financial-statement-focused press announcements, or potentially 'Regulatory Filings' (RNS) if ER is strictly reserved for financial results. Given the nature of the announcement (FDA approval), it is a significant corporate update. In the absence of specific categories for 'Regulatory Approval Announcements,' 'ER' is the closest fit for a major, time-sensitive press release announcing a key operational/regulatory milestone, although 'RNS' is a strong secondary candidate as a general regulatory announcement fallback. I will classify it as ER as it functions as a major news release. FY 2014
2014-02-19 English
Communiqué de presse
Regulatory Filings Classification · 95% confidence The document is titled '# **Communiqué de presse**' (Press Release) and details a specific corporate event: the FDA approval of a new production site for Lipiodol® in Canada, which impacts US supply. It includes standard press release elements like a date, quotes from management, company background ('A propos de Guerbet'), and forward-looking statements ('Déclarations prospectives'). This format is characteristic of an initial announcement of material news, which aligns best with the 'Earnings Release' (ER) definition if it were financial results, but since it is a specific operational/regulatory announcement that doesn't fit other specific categories (like M&A, Capital Change, or Director Dealing), it falls under the general category for non-standard regulatory announcements. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release announcing regulatory/operational milestones that isn't a formal SEC filing like a 10-K or a specific financial report like an IR or ER.
2014-02-19 French
Communiqué de presse
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly references compliance with French commercial code (L. 233-8 II) and AMF regulations (article 222-12-5), stating that the company publishes the total number of voting rights and shares monthly if they have changed. The content is a table showing the total shares, treasury shares, and total/exercisable voting rights as of January 31, 2014. This specific type of mandatory monthly disclosure regarding voting rights and capital structure aligns directly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it is a formal declaration related to shareholder voting power and capital structure changes.
2014-02-17 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.